Surgical post-opérative complications in neoadjuvant treatment including Bevacizumab for HER2-positive inflammatory breast cancer: results from a phase II prospective trial

ASCO 2011 – Poster #569

R. Rouzier, E. Lambaudie, J.Y, Pierga, T. Petit, T. Delozier, J.M, Ferrero, M. Campone, J. Gligorov, F. Lerebours, H. Roché, D. Pau, P. Viens, R.J. Salmon

Vous souhaitez échanger
avec nos équipes

D’autres articles qui pourraient
vous intéresser

Risk Factors TFR CP-CML

Success stories - Oncologie - Facultatif

Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients

Long-Term TKI Treatment Patterns

Success stories - Oncologie - Facultatif

Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in “Real-Life”

Use of Digital Health Technology to Enable Drug Development

Oncologie

Use of Digital Health Technology to Enable Drug Development